Form 4 for SNDX Syndax Pharmaceuticals Inc
Accepted 2022-07-08 00:00:00 ET · period of report 2022-07-06 · accession 0001562180-22-005637 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-07-08 | 2022-07-06+ | SNDX | Metzger Michael A | CEO, Dir | M - OptEx | $6.38 | +15.1K | 17.8K | +570% | +$96.4K |
| DM | 2022-07-08 | 2022-07-06+ | SNDX | Metzger Michael A | CEO, Dir | S - Sale+OE | $21.07 | -15.1K | 17.7K | -46% | -$318.3K |
| DM | 2022-07-08 | 2022-07-06+ | SNDX | Metzger Michael A | CEO, Dir | M - OptEx | $0.00 | -15.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-06 | M | A | 15,009 | $6.38 | 32,668 | D | — | — | |
| 2 | Common | Common Stock | 2022-07-06 | S | D | 15,009 | $21.07 | 17,659 | D | — | — | (F2) The sale prices ranged from $21.00 to $21.25. |
| 3 | Common | Common Stock | 2022-07-07 | M | A | 100 | $6.38 | 17,759 | D | — | — | |
| 4 | Common | Common Stock | 2022-07-07 | S | D | 100 | $21.00 | 17,659 | D | — | — | |
| 5 | Derivative | Stock Options (Right to buy) | 2022-07-06 | M | D | 15,009 | $0.00 | 0 | D | $6.38 · — to 2029-02-06 | 15,009 Common Stock | (F3) This option vests periodically upon the Issuer achieving certain milestones. |
| 6 | Derivative | Stock Options (Right to buy) | 2022-07-07 | M | D | 100 | $0.00 | 0 | D | $6.38 · — to 2029-02-06 | 100 Common Stock | (F3) This option vests periodically upon the Issuer achieving certain milestones. |